Literature DB >> 31305693

Erratum: Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum.

.   

Abstract

[This corrects the article DOI: 10.1097/MD.0000000000006985.].

Entities:  

Year:  2017        PMID： 31305693      PMCID： PMC5521951          DOI： 10.1097/MD.0000000000007644

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


In the article, “Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report”,[ which appeared in Volume 96, Issue 21 of Medicine, “Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China” should have appeared as “Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.”
  1 in total

1.  Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.

Authors:  Jin-Yan Liang; Fan Tong; Fei-Fei Gu; Yang-Yang Liu; Yu-Lan Zeng; Xiao-Hua Hong; Kai Zhang; Li Liu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.